Page last updated: 2024-11-05

benzylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

aminotoluene : Any member of the class of toluenes carrying one or more amino groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
MoringagenusA plant genus of the family Moringaceae, order Capparales, subclass Dilleniidae, class Magnoliopsida.[MeSH]Moringaceae[no description available]
Moringa oleiferaspeciesA plant species of the family Moringaceae, order Capparales, subclass Dilleniidae. It is a source of niaziminin and hypotensive thiocarbamate glycosides.[MeSH]Moringaceae[no description available]

Cross-References

ID SourceID
PubMed CID7504
CHEMBL ID522
CHEBI ID40538
SCHEMBL ID373
MeSH IDM0097154

Synonyms (96)

Synonym
BRD-K76133116-001-01-2
phenylmethylamine
.omega.-aminotoluene
benzylamine ,
benzenemethanamine
monobenzylamine
100-46-9
.alpha.-aminotoluene
(phenylmethyl)amine
nsc8046
nsc-8046
CHEBI:40538 ,
n-benzylamine
omega-aminotoluene
einecs 202-854-1
hsdb 2795
nsc 8046
brn 0741984
moringine
alpha-aminotoluene
sumine 2006
(aminomethyl)benzene
sumine 2005
ai3-15299
phenylmethanamine
inchi=1/c7h9n/c8-6-7-4-2-1-3-5-7/h1-5h,6,8h
1-phenylmethanamine
toluene,alpha-amino
ABN ,
benzylamine, analytical standard
quadrapure(r) bza, 400-1100 mum, extent of labeling: 20 mg/g loading, macroporous
DB02464
NCGC00166029-01
1UTN ,
2BZA ,
1UTJ ,
benzylamine, purified by redistillation, >=99.5%
benzylamine, reagentplus(r), 99%
NCIOPEN2_007746
3F830B2A-ABAA-4E26-971C-53B1C7485954
B0406
CHEMBL522 ,
aminotoluene
AKOS000119096
NCGC00166029-02
STL115534
benzyl-amine
4-12-00-02155 (beilstein handbook reference)
a1o31ror09 ,
ec 202-854-1
unii-a1o31ror09
dtxcid201839
dtxsid5021839 ,
cas-100-46-9
tox21_300933
NCGC00254835-01
benzyl amine
FT-0622836
FT-0622834
EPITOPE ID:141489
bdbm10999
SCHEMBL373
lacosamide impurity j [ep impurity]
benzylamine [mi]
benzylamine [hsdb]
benzyl-d7-amine
benzylarnine
bnnh2
bezylamine
bzl-nh2
n-(phenylmethyl)amine
nh2bn
aminomethylbenzene
mfcd00130502
89551-24-6
STR00195
benzyl-2,3,4,5,6-d5-amine
1219802-81-9
mfcd00008106
mfcd00145849
mfcd00135579
F2190-0388
a-aminotoluene
benzylamine, reagent grade
benzylamine, for gc derivatization, >=99.0%
quadrapure(tm) benzylamine
quadrapure(tm) bza
laquo omegaraquo -aminotoluene
benzenemethanamine, 9ci
Q424000
tetracyclohexylorthosilicate
benzylamine; 1-phenylmethanamine; lacosamide imp. j (pharmeuropa)
EN300-16215
BP-31247
lacosamide impurity j (ep impurity)
phenylmethyl amine

Research Excerpts

Overview

Benzylamine is a valuable intermediate in the synthesis of organic compounds such as curing agents and antifungal drugs. It is capable of activating hexose uptake and inhibiting lipolysis in human fat cells.

ExcerptReferenceRelevance
"Benzylamine is a natural molecule present in food and edible plants, capable of activating hexose uptake and inhibiting lipolysis in human fat cells. "( Effects of Chemical Structures Interacting with Amine Oxidases on Glucose, Lipid and Hydrogen Peroxide Handling by Human Adipocytes.
Carpéné, C; Dunkel, P; Földi, AÁ; Iffiú-Soltesz, Z; Mátyus, P; Tapolcsányi, P; Viana, P, 2022
)
2.16
"Benzylamine is a valuable intermediate in the synthesis of organic compounds such as curing agents and antifungal drugs. "( Optimization of multi-enzyme cascade process for the biosynthesis of benzylamine.
Dong, R; Gao, H; Liang, J; Wang, J; Yin, J, 2023
)
2.59

Actions

ExcerptReferenceRelevance
"HFD-benzylamine mice showed lower body weight gain, fasting blood glucose, total plasma cholesterol and hyperglycaemic response to glucose load when compared to HFD control."( Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice.
Alfredo Martinez, J; Bour, S; Carpéné, C; Iffiú-Soltész, Z; Lomba, A; Milagro, FI; Pellati, F; Portillo, MP; Szöko, E; Valet, P; Wanecq, E; Woodley, J, 2010
)
1.28

Treatment

Benzylamine treatment improved glucose tolerance but failed to normalize the elevated glucose fasting plasma levels of VHFD mice.

ExcerptReferenceRelevance
"Benzylamine treatment improved glucose tolerance as shown by the reduction of hyperglycemic response to intra-peritoneal glucose load."( Effects of oral administration of benzylamine on glucose tolerance and lipid metabolism in rats.
Bour, S; Carpéné, C; Daviaud, D; Guigne, C; Prévot, D; Saulnier-Blache, JS; Valet, P; Visentin, V, 2005
)
1.33
"Benzylamine treatment improved glucose tolerance but failed to normalize the elevated glucose fasting plasma levels of VHFD mice."( Influence of acute and chronic administration of benzylamine on glucose tolerance in diabetic and obese mice fed on very high-fat diet.
Bour, S; Burcelin, R; Carpéné, C; Fernández-Quintela, A; Grés, S; Iffiú-Soltész', Z; Knauf, C; Lomba, A; Milagro, FI; Prévot, D; Szökö, E, 2007
)
1.32

Toxicity

ExcerptReferenceRelevance
" Our data show that AA and its aldehyde metabolite, acrolein, were the most toxic compounds to both cell types."( Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity.
Boor, PJ; Conklin, DJ; Langford, SD, 1998
)
0.3

Pharmacokinetics

ExcerptReferenceRelevance
" The simple and quantitative derivatization coupled with tandem mass spectrometric analysis yields a sensitive and robust method for the quantification of (5R)-hydroxytriptolide in Phase I pharmacokinetic studies."( Derivatization of (5R)-hydroxytriptolide from benzylamine to enhance mass spectrometric detection: application to a Phase I pharmacokinetic study in humans.
Chen, X; Li, L; Liu, J; Liu, K; Miao, H; Zhang, Y; Zhong, D, 2011
)
0.63

Bioavailability

ExcerptReferenceRelevance
"Evidence is given that demonstrates the reliability of the bihyperbolic equation, proposed by Plá-Delfina and Moreno, in fitting the correlation between absorption rate constants (ka) found in the small intestine and in the colon of the living anesthetized rat, and partition constants (1/RF-1), for a series of phenylalkylamines, a group of compounds which differ largely from others which have been tested."( Studies on the reliability of a bihyperbolic functional absorption model. II. Phenylalkylamines.
Casabó, VG; Martín-Villodre, A; Martínez-Coscollá, A; Miralles-Loyola, E; Núñez-Benito, E; Plá-Delfina, JM, 1987
)
0.27
"3 nM) that are trypsin-selective, highly orally bioavailable in rats, and highly permeable across Caco-2 cells."( Benzylamine-based selective and orally bioavailable inhibitors of thrombin.
Hong, CY; Jung, WH; Kim, IC; Kim, S; Kim, SW; Kwon, OH; Lee, K; Lee, SH; Lee, YH; Oh, YS; Park, CW; Park, HD; Yoo, YJ, 1998
)
1.74
" However, it reduced the elevated serum SSAO activity, decreased the accumulation of advanced-glycation end products and increased the bioavailability of nitric oxide in diabetic animals, similarly to insulin."( Studies on the insulinomimetic effects of benzylamine, exogenous substrate of semicarbazide-sensitive amine oxidase enzyme in streptozotocin induced diabetic rats.
Halász, AS; Kocsis, E; Magyar, K; Pálfi, M; Soltész, Z; Szökö, E; Tábi, T; Tóth, M, 2007
)
0.6
" Further modifications led to the identification of potent, selective, and orally bioavailable uPA inhibitors."( Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA).
Adler, M; Arnaiz, D; Bryant, J; Chen, D; Chu, K; Gualtieri, G; Ho, E; Huwe, C; Light, D; Phillips, G; Pulk, R; Sukovich, D; West, CW; Whitlow, M; Yuan, S, 2009
)
0.35
" The project team was able to improve the bioavailability by reducing efflux through systematic modifications to the strength of the HBA by changing the electronic properties of neighboring groups, whilst maintaining sufficient acceptor strength for potency."( Modulating the strength of hydrogen bond acceptors to achieve low Caco2 efflux for oral bioavailability of PARP inhibitors blocking centrosome clustering.
Eisman, MS; Gu, C; Harrison, RA; Hu, H; Johannes, JW; Kazmirski, S; Lamb, ML; Lyne, PD; Mikule, K; Peng, B; Scott, DA; Su, N; Sylvester, MA; Wang, W; Ye, Q; Zheng, X, 2016
)
0.43
" The improvement of glucose homeostasis was observed in db-/- mice at the expense of increased fat deposition, especially in the subcutaneous white adipose tissue (SCWAT), without sign of worsened inflammation or insulin responsiveness and with lowered circulating triglycerides and uric acid, while NO bioavailability was increased in aorta."( Oral Supplementation with Benzylamine Delays the Onset of Diabetes in Obese and Diabetic db-/- Mice.
Carpéné, C; Iffiú-Soltesz, Z; Szökő, É; Tóthfalusi, L; Wanecq, E, 2021
)
0.92

Dosage Studied

ExcerptRelevanceReference
" These results suggest that MET is endowed with peculiar hypophagic effects at dosage levels that are not able to affect gross behaviour in mice."( Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels.
Banchelli, G; Galeotti, N; Ghelardini, C; Pirisino, R; Raimondi, L, 2001
)
0.66
" LC/MS analysis of bile and urine obtained from rats dosed with 1:1 equimolar mixture of either d(0):d(7)- or d(0):d(2)-benzylamine showed the presence of several glutathione adducts in addition to the hippuric acid metabolite."( Bioactivation of benzylamine to reactive intermediates in rodents: formation of glutathione, glutamate, and peptide conjugates.
Chen, SY; Daniels, JS; Dickenson, P; Espina, RJ; Gan, LS; Mutlib, AE, 2002
)
0.86
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
EC 3.5.5.1 (nitrilase) inhibitorAn EC 3.5.5.* (hydrolase acting on C-N bonds in nitriles) inhibitor that interferes with the action of nitrilase (EC 3.5.5.1).
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
allergenA chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
primary amineA compound formally derived from ammonia by replacing one hydrogen atom by a hydrocarbyl group.
aralkylamineAn alkylamine in which the alkyl group is substituted by an aromatic group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (19)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency11.22020.003245.467312,589.2998AID2517
retinoid X nuclear receptor alphaHomo sapiens (human)Potency27.53570.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency53.58020.001530.607315,848.9004AID1224849; AID1259403
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, PROTEIN (TRYPSIN)Bos taurus (cattle)Ki1,580.000018.4000799.20001,580.0000AID977610
Chain A, PROTEIN (TRYPSIN)Bos taurus (cattle)Ki1,580.000018.4000799.20001,580.0000AID977610
Trypsin-1Homo sapiens (human)Ki299,916.00000.00001.76768.9000AID215915
Phenylethanolamine N-methyltransferaseBos taurus (cattle)Ki1,874,470,175.00000.00312.329310.0000AID155135; AID156064; AID313558
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)Ki25,059,350,538.00000.00000.929610.0000AID35395; AID37364
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)Ki25,059,350,538.00000.00000.970810.0000AID35395; AID37364
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)Ki25,059,350,538.00000.00000.937510.0000AID35395; AID37364
Lysyl oxidase homolog 2Homo sapiens (human)IC50 (µMol)64.70000.06600.56494.2600AID1430567
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Steroid C26-monooxygenaseMycobacterium tuberculosis CDC1551Kd6,662.36670.10002.59676.1000AID1799801
Cytochrome P450 130Mycobacterium tuberculosis CDC1551Kd6,662.36670.10002.59206.1000AID1799801
Cytochrome P450 130Mycobacterium tuberculosis H37RvKd6,662.36670.10002.59206.1000AID1799801
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (29)

Processvia Protein(s)Taxonomy
digestionTrypsin-1Homo sapiens (human)
extracellular matrix disassemblyTrypsin-1Homo sapiens (human)
proteolysisTrypsin-1Homo sapiens (human)
methylationPhenylethanolamine N-methyltransferaseBos taurus (cattle)
epinephrine biosynthetic processPhenylethanolamine N-methyltransferaseBos taurus (cattle)
putrescine metabolic processAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
response to antibioticAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
amine metabolic processAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
inflammatory responseMembrane primary amine oxidaseHomo sapiens (human)
cell adhesionMembrane primary amine oxidaseHomo sapiens (human)
amine metabolic processMembrane primary amine oxidaseHomo sapiens (human)
response to antibioticMembrane primary amine oxidaseHomo sapiens (human)
negative regulation of primary amine oxidase activityMembrane primary amine oxidaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IILysyl oxidase homolog 2Homo sapiens (human)
response to hypoxiaLysyl oxidase homolog 2Homo sapiens (human)
epithelial to mesenchymal transitionLysyl oxidase homolog 2Homo sapiens (human)
endothelial cell proliferationLysyl oxidase homolog 2Homo sapiens (human)
sprouting angiogenesisLysyl oxidase homolog 2Homo sapiens (human)
positive regulation of epithelial to mesenchymal transitionLysyl oxidase homolog 2Homo sapiens (human)
peptidyl-lysine oxidationLysyl oxidase homolog 2Homo sapiens (human)
collagen fibril organizationLysyl oxidase homolog 2Homo sapiens (human)
positive regulation of chondrocyte differentiationLysyl oxidase homolog 2Homo sapiens (human)
protein modification processLysyl oxidase homolog 2Homo sapiens (human)
endothelial cell migrationLysyl oxidase homolog 2Homo sapiens (human)
negative regulation of DNA-templated transcriptionLysyl oxidase homolog 2Homo sapiens (human)
response to copper ionLysyl oxidase homolog 2Homo sapiens (human)
heterochromatin organizationLysyl oxidase homolog 2Homo sapiens (human)
negative regulation of stem cell population maintenanceLysyl oxidase homolog 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (22)

Processvia Protein(s)Taxonomy
serine-type endopeptidase activityTrypsin-1Homo sapiens (human)
metal ion bindingTrypsin-1Homo sapiens (human)
phenylethanolamine N-methyltransferase activityPhenylethanolamine N-methyltransferaseBos taurus (cattle)
copper ion bindingAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
calcium ion bindingAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
protein bindingAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
primary amine oxidase activityAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
heparin bindingAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
protein homodimerization activityAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
quinone bindingAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
putrescine oxidase activityAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
diamine oxidase activityAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
histamine oxidase activityAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
methylputrescine oxidase activityAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
propane-1,3-diamine oxidase activityAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BBos taurus (cattle)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BBos taurus (cattle)
monoamine oxidase activityAmine oxidase [flavin-containing] BBos taurus (cattle)
copper ion bindingMembrane primary amine oxidaseHomo sapiens (human)
calcium ion bindingMembrane primary amine oxidaseHomo sapiens (human)
protein bindingMembrane primary amine oxidaseHomo sapiens (human)
primary amine oxidase activityMembrane primary amine oxidaseHomo sapiens (human)
identical protein bindingMembrane primary amine oxidaseHomo sapiens (human)
protein heterodimerization activityMembrane primary amine oxidaseHomo sapiens (human)
quinone bindingMembrane primary amine oxidaseHomo sapiens (human)
aliphatic amine oxidase activityMembrane primary amine oxidaseHomo sapiens (human)
protein-lysine 6-oxidase activityLysyl oxidase homolog 2Homo sapiens (human)
copper ion bindingLysyl oxidase homolog 2Homo sapiens (human)
calcium ion bindingLysyl oxidase homolog 2Homo sapiens (human)
protein bindingLysyl oxidase homolog 2Homo sapiens (human)
oligosaccharide bindingLysyl oxidase homolog 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (23)

Processvia Protein(s)Taxonomy
extracellular regionTrypsin-1Homo sapiens (human)
collagen-containing extracellular matrixTrypsin-1Homo sapiens (human)
blood microparticleTrypsin-1Homo sapiens (human)
extracellular spaceTrypsin-1Homo sapiens (human)
extracellular spaceAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
extracellular regionAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
extracellular spaceAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
peroxisomeAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
plasma membraneAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
bicellular tight junctionAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
specific granule lumenAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
extracellular exosomeAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
plasma membraneAmiloride-sensitive amine oxidase [copper-containing]Homo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BBos taurus (cattle)
mitochondrial outer membraneAmine oxidase [flavin-containing] BBos taurus (cattle)
cytoplasmMembrane primary amine oxidaseHomo sapiens (human)
plasma membraneMembrane primary amine oxidaseHomo sapiens (human)
microvillusMembrane primary amine oxidaseHomo sapiens (human)
cell surfaceMembrane primary amine oxidaseHomo sapiens (human)
membraneMembrane primary amine oxidaseHomo sapiens (human)
early endosomeMembrane primary amine oxidaseHomo sapiens (human)
endoplasmic reticulumMembrane primary amine oxidaseHomo sapiens (human)
Golgi apparatusMembrane primary amine oxidaseHomo sapiens (human)
early endosomeMembrane primary amine oxidaseHomo sapiens (human)
plasma membraneMembrane primary amine oxidaseHomo sapiens (human)
endoplasmic reticulumMembrane primary amine oxidaseHomo sapiens (human)
Golgi apparatusMembrane primary amine oxidaseHomo sapiens (human)
collagen-containing extracellular matrixLysyl oxidase homolog 2Homo sapiens (human)
basement membraneLysyl oxidase homolog 2Homo sapiens (human)
extracellular spaceLysyl oxidase homolog 2Homo sapiens (human)
nucleusLysyl oxidase homolog 2Homo sapiens (human)
nucleoplasmLysyl oxidase homolog 2Homo sapiens (human)
endoplasmic reticulumLysyl oxidase homolog 2Homo sapiens (human)
membraneLysyl oxidase homolog 2Homo sapiens (human)
collagen-containing extracellular matrixLysyl oxidase homolog 2Homo sapiens (human)
chromatinLysyl oxidase homolog 2Homo sapiens (human)
collagen-containing extracellular matrixLysyl oxidase homolog 2Homo sapiens (human)
extracellular spaceLysyl oxidase homolog 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (83)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID488083Activity at baboon liver mitochondrial MAO-B assessed as H2O2 production at 500 uM after 6 to 15 mins pretreated with (R)-deprenyl2010Bioorganic & medicinal chemistry, Jun-01, Volume: 18, Issue:11
Interactions of 1-methyl-3-phenylpyrrolidine and 3-methyl-1-phenyl-3-azabicyclo[3.1.0]hexane with monoamine oxidase B.
AID125407Kinetic constant (Km) determined in rat brain mitochondria1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Flexible N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogues: synthesis and monoamine oxidase catalyzed bioactivation.
AID273099Binding affinity to human SSAO2006Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21
New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
AID239765Michaelis-Menten constant for semicarbazide-sensitive amine oxidase (SSAO) from human, rat or mouse crude membranes2004Journal of medicinal chemistry, Sep-23, Volume: 47, Issue:20
Exploring the binding mode of semicarbazide-sensitive amine oxidase/VAP-1: identification of novel substrates with insulin-like activity.
AID18741Selectivity of guest-induced changes in membrane potential(Kpot A,B) at pH 5.0 for PVC matrix liquid membranes incorporated with 6,7,9,10,17,18,20,21-Octahydro-5,8,11,16,19,22-hexaoxa-dibenzo[a,j]cyclooctadecene1999Bioorganic & medicinal chemistry letters, Aug-16, Volume: 9, Issue:16
Dopamine-selective response in membrane potential by homooxacalix[3]arene triether host incorporated in PVC liquid membrane.
AID125532Kinetic constant (Vmax) determined in rat brain mitochondria.1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Flexible N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogues: synthesis and monoamine oxidase catalyzed bioactivation.
AID242942Ratio of Vmax/Km for human, mouse or rat SSAO2004Journal of medicinal chemistry, Sep-23, Volume: 47, Issue:20
Exploring the binding mode of semicarbazide-sensitive amine oxidase/VAP-1: identification of novel substrates with insulin-like activity.
AID125535Tested for pargyline-induced inhibition of MAO-catalyzed oxidation in rat brain mitochondria (Specific inhibitor = Pargyline hydrochloride at 2.5 uM) (Control = 16.68)1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Flexible N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogues: synthesis and monoamine oxidase catalyzed bioactivation.
AID353103Displacement of [3H]MK801 from NMDA receptor in rat brain neuronal membrane2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds.
AID102891Oxidation by bovine mono-amine oxidase B MAO-B1994Journal of medicinal chemistry, Apr-01, Volume: 37, Issue:7
Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates.
AID1526718Substrate activity at recombinant human SSAO assessed as compound oxidation by measuring oxidative turnover at 600 uM measured for 40 mins by horseradish peroxidase-coupled amplex red reagent-based fluorometric assay relative to DMSO2019Journal of medicinal chemistry, 11-14, Volume: 62, Issue:21
Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3.
AID1269975Antimicrobial activity against Escherichia coli K-12 MG1655 after 24 hrs by double dilution method2015MedChemComm, May-01, Volume: 6, Issue:5
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.
AID353104Ratio of Ki for rat brain NMDA receptor in presence of 100 uM spermine to Ki for rat brain NMDA receptor in absence of spermine2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds.
AID1708451Inhibition of human thrombin using Tos-Gly-Pro-Arg-AMC.TFA substrate by fluorescence based kinetic enzyme inhibition assay based Dixon plot analysis2021Journal of medicinal chemistry, 02-11, Volume: 64, Issue:3
How a Fragment Draws Attention to Selectivity Discriminating Features between the Related Proteases Trypsin and Thrombin.
AID242909Maximum velocity for semicarbazide-sensitive amine oxidase (SSAO) of human, mouse or rat crude membranes2004Journal of medicinal chemistry, Sep-23, Volume: 47, Issue:20
Exploring the binding mode of semicarbazide-sensitive amine oxidase/VAP-1: identification of novel substrates with insulin-like activity.
AID229906Selectivity ratio between Ki of alpha-2 adrenoceptor and Ki of PNMT1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
Effect of ring size or an additional heteroatom on the potency and selectivity of bicyclic benzylamine-type inhibitors of phenylethanolamine N-methyltransferase.
AID313560Selectivity of Ki for bovine PNMT over Ki for rat alpha-2 adrenoceptor2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Synthesis of 4,5,6,7-tetrahydrothieno[3,2-c]pyridines and comparison with their isosteric 1,2,3,4-tetrahydroisoquinolines as inhibitors of phenylethanolamine N-methyltransferase.
AID18739Selectivity of guest-induced changes in membrane potential at pH 5.0 for PVC matrix liquid membranes incorporated with (2-Butoxy-5-tert-butyl-3-methyl-phenyl)-methanol polymer1999Bioorganic & medicinal chemistry letters, Aug-16, Volume: 9, Issue:16
Dopamine-selective response in membrane potential by homooxacalix[3]arene triether host incorporated in PVC liquid membrane.
AID155316Molar pI50 value for phenylethanolamine N-methyl-transferase (PNMT) inhibition1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
Conformational and steric aspects of the inhibition of phenylethanolamine N-methyltransferase by benzylamines.
AID231695Ratio between TN and Km against MAO A1993Journal of medicinal chemistry, Apr-30, Volume: 36, Issue:9
Molecular size and flexibility as determinants of selectivity in the oxidation of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs by monoamine oxidase A and B.
AID304716Increase in caspase 7 activation in human SKBR3 cells at 20 uM after 24 hrs2007Journal of medicinal chemistry, Dec-27, Volume: 50, Issue:26
Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
AID18736Selectivity of guest-induced changes in membrane potential at pH 5.0 for PVC matrix liquid membrane without any host1999Bioorganic & medicinal chemistry letters, Aug-16, Volume: 9, Issue:16
Dopamine-selective response in membrane potential by homooxacalix[3]arene triether host incorporated in PVC liquid membrane.
AID239730Km for Benzylamine oxidase of porcine serum2005Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
Alkylamino derivatives of 4-aminomethylpyridine as inhibitors of copper-containing amine oxidases.
AID102566Michaelis-Menten constant against MAO A.1993Journal of medicinal chemistry, Apr-30, Volume: 36, Issue:9
Molecular size and flexibility as determinants of selectivity in the oxidation of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs by monoamine oxidase A and B.
AID125534Percent inhibition of MAO-catalyzed oxidation in rat brain mitochondria induced by pargyline1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Flexible N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogues: synthesis and monoamine oxidase catalyzed bioactivation.
AID1269980Antimicrobial activity against Staphylococcus aureus RN4220 after 24 hrs by double dilution method2015MedChemComm, May-01, Volume: 6, Issue:5
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.
AID215915The compound was tested for inhibition of the proteolytic enzyme trypsin.1999Journal of medicinal chemistry, Dec-16, Volume: 42, Issue:25
Simple linear QSAR models based on quantum similarity measures.
AID273102Stimulation of glucose transport in mouse adipocytes at 1 mM in presence of sodium orthovanadate2006Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21
New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
AID304718Binding affinity to calf thymus dodecamer DNA assessed as thermal stability in cacodylate buffer at 12 uM2007Journal of medicinal chemistry, Dec-27, Volume: 50, Issue:26
Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
AID156064Inhibitory activity against bovine adrenal phenylethanolamine N-methyl-transferase (PNMT)1999Bioorganic & medicinal chemistry letters, Feb-08, Volume: 9, Issue:3
Comparative molecular field analysis (CoMFA) models of phenylethanolamine N-methyltransferase (PNMT) and the alpha2-adrenoceptor: the development of new, highly selective inhibitors of PNMT.
AID102576Turnover number against MAO B (umol of substrate/min per umol of enzyme).1993Journal of medicinal chemistry, Apr-30, Volume: 36, Issue:9
Molecular size and flexibility as determinants of selectivity in the oxidation of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs by monoamine oxidase A and B.
AID1134602Hexane-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID155135In vitro for inhibition of Phenylethanolamine N-Methyltransferase (PNMT)1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
Effect of ring size or an additional heteroatom on the potency and selectivity of bicyclic benzylamine-type inhibitors of phenylethanolamine N-methyltransferase.
AID1134599CHCl3-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID242901Vmax for Diamine oxidase of porcine kidney2005Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
Alkylamino derivatives of 4-aminomethylpyridine as inhibitors of copper-containing amine oxidases.
AID23236Partition coefficient (logP)1999Bioorganic & medicinal chemistry letters, Aug-16, Volume: 9, Issue:16
Dopamine-selective response in membrane potential by homooxacalix[3]arene triether host incorporated in PVC liquid membrane.
AID273098Activity of mouse SSAO measured as hydrogen peroxide production at 100 uM relative to benzylamine oxidation2006Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21
New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
AID488097Activity at baboon liver mitochondrial MAO-B assessed as initial rate of H2O2 production after 8 mins assessed per mg of mitochondrial protein2010Bioorganic & medicinal chemistry, Jun-01, Volume: 18, Issue:11
Interactions of 1-methyl-3-phenylpyrrolidine and 3-methyl-1-phenyl-3-azabicyclo[3.1.0]hexane with monoamine oxidase B.
AID37364In vitro for binding affinity against Alpha-2 adrenergic receptor by radioligand [3H]clonidine in rat1996Journal of medicinal chemistry, Aug-30, Volume: 39, Issue:18
Effect of ring size or an additional heteroatom on the potency and selectivity of bicyclic benzylamine-type inhibitors of phenylethanolamine N-methyltransferase.
AID229922Ratio of turnover to Km for bovine MAO-B1994Journal of medicinal chemistry, Apr-01, Volume: 37, Issue:7
Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates.
AID643449Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by ten-fold serial dilution method2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Design, synthesis, and evaluation of thiol-activated sources of sulfur dioxide (SO₂) as antimycobacterial agents.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID488099Ratio of Vmax to Km for baboon liver mitochondrial MAO-B assessed per mg of protein after 8 mins2010Bioorganic & medicinal chemistry, Jun-01, Volume: 18, Issue:11
Interactions of 1-methyl-3-phenylpyrrolidine and 3-methyl-1-phenyl-3-azabicyclo[3.1.0]hexane with monoamine oxidase B.
AID1269978Antimicrobial activity against Bacillus cereus ATCC 11778 after 24 hrs by double dilution method2015MedChemComm, May-01, Volume: 6, Issue:5
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.
AID225081Inhibition of phenylethanolamine N-methyltransferase(PNMT)activity1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
Quantitative structure-activity relationships employing independent quantum chemical indices.
AID304707Antiproliferative activity against human SKBR3 cells after 72 hrs2007Journal of medicinal chemistry, Dec-27, Volume: 50, Issue:26
Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
AID488098Activity at baboon liver mitochondrial MAO-B assessed as initial rate of H2O2 production after 8 mins2010Bioorganic & medicinal chemistry, Jun-01, Volume: 18, Issue:11
Interactions of 1-methyl-3-phenylpyrrolidine and 3-methyl-1-phenyl-3-azabicyclo[3.1.0]hexane with monoamine oxidase B.
AID273097Activity of human SSAO measured as hydrogen peroxide production at 1 mM relative to benzylamine oxidation2006Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21
New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
AID681336TP_TRANSPORTER: cell accumulation of 0.05u daunomycin in MCF-7/ADR cells2004Journal of pharmaceutical sciences, Jul, Volume: 93, Issue:7
Effects of benzyl-, phenethyl-, and alpha-naphthyl isothiocyanates on P-glycoprotein- and MRP1-mediated transport.
AID313558Inhibition of bovine PNMT by radiochemical assay2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Synthesis of 4,5,6,7-tetrahydrothieno[3,2-c]pyridines and comparison with their isosteric 1,2,3,4-tetrahydroisoquinolines as inhibitors of phenylethanolamine N-methyltransferase.
AID273100Binding affinity to mouse SSAO2006Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21
New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
AID1430567Inhibition of full length recombinant human LOXL2 expressed in CHO cells assessed as reduction in H2O2 production using DAP as substrate preincubated for 2 hrs followed by substrate addition measured every 2 minutes for 50 minutes by Amplex red dye based 2017ACS medicinal chemistry letters, Apr-13, Volume: 8, Issue:4
Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX.
AID35395Inhibition of [3H]clonidine binding to the rat alpha-2-adrenoceptor1999Bioorganic & medicinal chemistry letters, Feb-08, Volume: 9, Issue:3
Comparative molecular field analysis (CoMFA) models of phenylethanolamine N-methyltransferase (PNMT) and the alpha2-adrenoceptor: the development of new, highly selective inhibitors of PNMT.
AID18738Selectivity of guest-induced changes in membrane potential at pH 5.0 for PVC matrix liquid membranes incorporated with o-Tolyloxy-acetic acid ethyl ester polymer1999Bioorganic & medicinal chemistry letters, Aug-16, Volume: 9, Issue:16
Dopamine-selective response in membrane potential by homooxacalix[3]arene triether host incorporated in PVC liquid membrane.
AID125530Ratio of Kinetic constants (Km vs. Vmax).1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Flexible N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogues: synthesis and monoamine oxidase catalyzed bioactivation.
AID1321514Dissociation constant, pKa of the compound2016Bioorganic & medicinal chemistry letters, 10-01, Volume: 26, Issue:19
Modulating the strength of hydrogen bond acceptors to achieve low Caco2 efflux for oral bioavailability of PARP inhibitors blocking centrosome clustering.
AID155317Acid dissociation constant of phenylethanolamine N-methyl-transferase (PNMT) inhibition1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
Conformational and steric aspects of the inhibition of phenylethanolamine N-methyltransferase by benzylamines.
AID102567Turnover number against MAO A (umol of substrate/min per umol of enzyme).1993Journal of medicinal chemistry, Apr-30, Volume: 36, Issue:9
Molecular size and flexibility as determinants of selectivity in the oxidation of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs by monoamine oxidase A and B.
AID18737Selectivity of guest-induced changes in membrane potential at pH 5.0 for PVC matrix liquid membranes incorporated with o-Tolyloxy-acetic acid decyl ester polymer1999Bioorganic & medicinal chemistry letters, Aug-16, Volume: 9, Issue:16
Dopamine-selective response in membrane potential by homooxacalix[3]arene triether host incorporated in PVC liquid membrane.
AID102892Turnover number (TN) for bovine mono-amine oxidase B MAO-B1994Journal of medicinal chemistry, Apr-01, Volume: 37, Issue:7
Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates.
AID313559Displacement of [3H]clonidine from adrenergic alpha-1 receptor in Sprague-Dawley rat cortex2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Synthesis of 4,5,6,7-tetrahydrothieno[3,2-c]pyridines and comparison with their isosteric 1,2,3,4-tetrahydroisoquinolines as inhibitors of phenylethanolamine N-methyltransferase.
AID239728Km for Diamine oxidase of porcine kidney2005Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
Alkylamino derivatives of 4-aminomethylpyridine as inhibitors of copper-containing amine oxidases.
AID1269976Antimicrobial activity against Haemophilus influenzae ATCC 51907 after 24 hrs by double dilution method2015MedChemComm, May-01, Volume: 6, Issue:5
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.
AID231696Ratio of turnover number(TN)and Km for MAO B1993Journal of medicinal chemistry, Apr-30, Volume: 36, Issue:9
Molecular size and flexibility as determinants of selectivity in the oxidation of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs by monoamine oxidase A and B.
AID1134600Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1526723Substrate activity at AOC4 in dog serum assessed as compound oxidation by measuring oxidative turnover at 600 uM measured for 40 mins by horseradish peroxidase-coupled amplex red reagent-based fluorometric assay relative to DMSO2019Journal of medicinal chemistry, 11-14, Volume: 62, Issue:21
Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3.
AID1708455Inhibition of human trypsin using Mes-D-Arg-Gly-Arg-AMC.2TFA substrate by fluorescence based kinetic enzyme inhibition assay based Dixon plot analysis2021Journal of medicinal chemistry, 02-11, Volume: 64, Issue:3
How a Fragment Draws Attention to Selectivity Discriminating Features between the Related Proteases Trypsin and Thrombin.
AID1269979Antimicrobial activity against Bacillus subtilis 168 after 24 hrs by double dilution method2015MedChemComm, May-01, Volume: 6, Issue:5
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.
AID242903Vmax for porcine serum Benzylamine oxidase2005Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
Alkylamino derivatives of 4-aminomethylpyridine as inhibitors of copper-containing amine oxidases.
AID102575Michaelis-Menten constant against MAO B.1993Journal of medicinal chemistry, Apr-30, Volume: 36, Issue:9
Molecular size and flexibility as determinants of selectivity in the oxidation of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs by monoamine oxidase A and B.
AID304715Increase in caspase 3 activation in human SKBR3 cells at 20 uM after 24 hrs2007Journal of medicinal chemistry, Dec-27, Volume: 50, Issue:26
Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
AID304719Binding affinity to calf thymus dodecamer DNA assessed as thermal stability in cacodylate buffer containing 0.1 M NaCl at 12 uM2007Journal of medicinal chemistry, Dec-27, Volume: 50, Issue:26
Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
AID273101Stimulation of glucose transport in mouse adipocytes at 0.1 mM in presence of sodium orthovanadate2006Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21
New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
AID304717Binding affinity to calf thymus DNA assessed as thermal stability in BPE buffer at 2 uM2007Journal of medicinal chemistry, Dec-27, Volume: 50, Issue:26
Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
AID681791TP_TRANSPORTER: inhibition of PAH uptake (PAH: 2 uM, Benzydamine: 1000 uM) in Xenopus laevis oocytes1999Molecular pharmacology, May, Volume: 55, Issue:5
Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes.
AID1269977Antimicrobial activity against Bacillus anthracis 34F2 Sterne after 24 hrs by double dilution method2015MedChemComm, May-01, Volume: 6, Issue:5
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.
AID1799801Binding Assay from Article 10.1074/jbc.M109.017632: \\Interaction of Mycobacterium tuberculosis CYP130 with heterocyclic arylamines.\\2009The Journal of biological chemistry, Sep-11, Volume: 284, Issue:37
Interaction of Mycobacterium tuberculosis CYP130 with heterocyclic arylamines.
AID1803087Urease Inhibition Assay from Article 10.3109/14756366.2011.599065: \\Synthesis, inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease.\\2012Journal of enzyme inhibition and medicinal chemistry, Aug, Volume: 27, Issue:4
Synthesis, inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1999Proteins, Dec-01, Volume: 37, Issue:4
Non-Boltzmann thermodynamic integration (NBTI) for macromolecular systems: relative free energy of binding of trypsin to benzamidine and benzylamine.
AID1811Experimentally measured binding affinity data derived from PDB1999Proteins, Dec-01, Volume: 37, Issue:4
Non-Boltzmann thermodynamic integration (NBTI) for macromolecular systems: relative free energy of binding of trypsin to benzamidine and benzylamine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (371)

TimeframeStudies, This Drug (%)All Drugs %
pre-199064 (17.25)18.7374
1990's77 (20.75)18.2507
2000's118 (31.81)29.6817
2010's94 (25.34)24.3611
2020's18 (4.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 78.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index78.28 (24.57)
Research Supply Index5.97 (2.92)
Research Growth Index4.61 (4.65)
Search Engine Demand Index137.95 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (78.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (1.03%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other385 (98.97%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]